El Hospital Universitario Puerta del Mar es un complejo hospitalario gestionado por el Servicio Andaluz de Salud, ubicado en la ciudad española de Cádiz. Es el complejo sanitario de referencia de la provincia de Cádiz. Fue inaugurado el 20 de diciembre de 1977, perteneciente al Seguro Obligatorio de Enfermedad.

During the past decade, Hospital Universitario Puerta del Mar conducted 79 clinical trials. In the 10-year time frame, 79 clinical trials started and 19 clinical trials were completed, i.e. on average, 24.1% percent of trials that started reached the finish line to date. In the past 5 years, 31 clinical trials started and 3 clinical trials were completed. i.e. 9.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital Universitario Puerta del Mar" #1 sponsor was "PETHEMA Foundation" with 14 trials, followed by "Spanish Breast Cancer Research Group" with 11 trials sponsored, "Fundación Pública Andaluza para la gestión de la Investigación en Sevilla" with 6 trials sponsored, "Fundación EPIC" with 5 trials sponsored and "Fundación Pública Andaluza Progreso y Salud" with 5 trials sponsored. Other sponsors include 92 different institutions and companies that sponsored additional 76 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Universitario Puerta del Mar" #1 collaborator was "Hoffmann-La Roche" with 3 trials as a collaborator, "Iniciativa Andaluza en Terapias Avanzadas" with 3 trials as a collaborator, "Andalusian Network for Design and Translation of Advanced Therapies" with 2 trials as a collaborator, "Bristol-Myers Squibb" with 2 trials as a collaborator and "Dynamic Science S.L." with 2 trials as a collaborator. Other collaborators include 67 different institutions and companies that were collaborators in the rest 76 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Universitario Puerta del Mar" are "Breast Cancer" (11 trials), "Acute Lymphoblastic Leukemia" (4 trials), "Coronary Artery Disease" (4 trials), "Atrial Fibrillation" (3 trials) and "Cardiovascular Diseases" (3 trials). Many other conditions were trialed in "Hospital Universitario Puerta del Mar" in a lesser frequency.

Most popular intervention types in "Hospital Universitario Puerta del Mar" are "Drug" (80 trials), "Device" (16 trials), "Procedure" (16 trials), "Other" (15 trials) and "Biological" (7 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (13 trials), "Cyclophosphamide" (5 trials), "Cytarabine" (5 trials), "Idarubicin" (4 trials) and "Capecitabine" (3 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Universitario Puerta del Mar" are 114 trials for "All" genders, 17 trials for "Female" genders and 7 trials for "Male" genders.

Currently, there are NaN active trials in "Hospital Universitario Puerta del Mar". 2 are not yet recruiting, 22 are recruiting, 11 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 79 completed trials in Hospital Universitario Puerta del Mar, 1 suspended trials, and 11 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Universitario Puerta del Mar, 4 "Phase 1" clinical trials were conducted, 21 "Phase 2" clinical trials and 34 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 20 trials, and there were also 16 trials that are defined as “Not Applicable".

Hospital Universitario Puerta del Mar has several departments that took part in Clinical trials: "Hospital Puerta del Mar; Sevicio de Neurologia" - 5 trials, "Hospital Universitario Puerta del Mar; Servicio de Hematologia" - 3 trials, "Hospital Universitario Puerta del Mar; Servicio de Oncologia" - 2 trials